Detection of mRNA for the terminal complement components C5, C6, C8 and C9 in human umbilical vein endothelial cells in vitro

被引:14
|
作者
Langeggen, H
Berge, KE
Macor, P
Fischetti, F
Tedesco, F
Hetland, G
Berg, K
Johnson, E
机构
[1] Univ Oslo, Ulleval Hosp, Dept Surg Gastroenterol, N-0407 Oslo, Norway
[2] Univ Oslo, Ulleval Hosp, Dept Med Genet, N-0407 Oslo, Norway
[3] Univ Trieste, Dept Physiol & Pathol, I-34127 Trieste, Italy
[4] Natl Inst Publ Hlth, Dept Environm Med, N-0462 Oslo, Norway
[5] Univ Oslo, Inst Med Genet, Oslo, Norway
关键词
mRNA; TCC; HUVEC;
D O I
10.1111/j.1600-0463.2001.tb00016.x
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Human umbilical vein endothelial cells (HUVEC) have previously been shown to synthesize the functional terminal pathway of complement based on the detection by radioimmunoassay of the terminal complement complex (TCC) on coincubated agarose beads. In addition, C7 secretion by these cells in amounts comparable to C3, as well as C7 mRNA, has recently been demonstrated. However, it has not been possible to detect C5-6 and C8 in the fluid phase, and only trace amounts of soluble C9. Against this background we examined whether mRNA for the remaining terminal complement factors was present in HUVEC. By the use of reverse transcription (RT)-polymerase chain reaction (PCR) and Northern blot the presence of mRNA for complement factors C5, C6, C8 and C9 was demonstrated.
引用
收藏
页码:73 / 78
页数:6
相关论文
共 50 条